Vitamin K comes in two main families with meaningfully different behaviour. K1, phylloquinone, comes from green leafy vegetables. K2, the menaquinones, comes from fermented foods and animal products. The difference that matters is where each one ends up.
What distinguishes them chemically?
Both share the same core structure and differ in the side chain attached to it. K1 has a single saturated side chain, while the menaquinones have chains of varying length made of repeating units.
They are named by that length. MK-4 has four units, MK-7 has seven, and longer forms exist. The chain length determines how the molecule is transported and how long it persists.
Where does each one go?
K1 is taken up rapidly by the liver, where it supports production of clotting factors. It clears from circulation within hours, with a half life commonly cited at around one to two hours.
MK-7 behaves very differently. It is carried on LDL particles, circulates for far longer with a half life measured in days, and reaches tissues outside the liver including bone and blood vessel walls.
MK-4 is also found in tissues and has a short half life, and the body can convert some K1 into MK-4, which complicates any simple account of dietary requirements.
Where do you get them?
- K1 from kale, spinach, broccoli, Brussels sprouts, spring greens and parsley
- MK-7 from natto, a fermented soya food, by an enormous margin the richest source
- MK-4 from animal foods including liver, egg yolk, butter and some meats
- Other menaquinones from aged cheeses, sauerkraut and other fermented products
K1 makes up the large majority of dietary vitamin K in Western diets. K2 intake is generally low unless someone eats natto regularly, which few people outside Japan do.
Does K2 have better evidence for bone?
The theory is that osteocalcin, a vitamin K dependent protein involved in bone mineralisation, is better served by a form that reaches bone tissue rather than being cleared by the liver.
Japanese trials using high dose MK-4, at 45mg daily, reported reduced fracture rates. Those doses are pharmacological rather than nutritional and far above what supplements contain, and replication outside Japan has been difficult.
MK-7 trials have shown improvements in markers of vitamin K status, and effects on bone density and fracture have been modest and inconsistent.
What about arteries?
Matrix Gla protein inhibits calcium deposition in artery walls and requires vitamin K to be activated, which is a plausible mechanism for the vascular claims.
Observational studies have associated higher K2 intake with less arterial calcification and lower cardiovascular mortality, and observational data of this kind is heavily confounded.
Randomised trials have reported effects on arterial stiffness in some populations and null results in others. It remains an interesting hypothesis rather than an established benefit.
Which should you take?
For clotting, which is the function with unambiguous clinical importance, K1 from green vegetables is entirely sufficient and easy to obtain.
For the bone and vascular claims, MK-7 is the form with the most plausible rationale, and the outcome evidence does not yet justify strong recommendations.
Eating leafy greens regularly covers vitamin K comfortably for most people without any supplement.
Who should avoid K2 supplements?
Anyone taking warfarin. This is important and easy to miss, because K2 is frequently sold combined with vitamin D3 rather than as a standalone product.
MK-7 is particularly relevant here because its long half life means it affects INR for longer than K1 would. Tell your anticoagulant clinic about any supplement you start or stop.
Should you eat natto?
Natto contains far more MK-7 than any other common food, by a very wide margin, and a small portion supplies more than most supplements deliver.
It is an acquired taste, with a strong smell and stringy texture many people find difficult. If K2 interests you it is the most direct dietary route, and cheese and egg yolk contribute smaller amounts more palatably.
This article is general information and not medical advice.